Gagnon Securities’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.9K Buy
88,405
+2,303
+3% +$2.43K 0.02% 85
2025
Q4
$88.7K Buy
86,102
+68,280
+383% +$91.8K 0.02% 86
2025
Q3
$38.7K Buy
+17,822
New +$29K 0.01% 86
2024
Q3
Sell
-4,641
Closed -$43K 103
2024
Q2
$43K Sell
4,641
-93
-2% -$1.03K 0.01% 96
2024
Q1
$62.7K Buy
4,734
+1,150
+32% +$20.5K 0.01% 94
2023
Q4
$131K Buy
3,584
+1,665
+87% +$34K 0.03% 96
2023
Q3
$24.5K Buy
+1,919
New +$50.2K 0.01% 96
2023
Q1
Sell
-332
Closed -$46.6K 114
2022
Q4
$46.6K Sell
332
-54
-14% -$23.4K 0.01% 103
2022
Q3
$194K Buy
386
+11
+3% +$9.58K 0.04% 91
2022
Q2
$327K Buy
375
+8
+2% +$11K 0.07% 82
2022
Q1
$926K Buy
367
+49
+15% +$116K 0.15% 58
2021
Q4
$821K Sell
318
-74
-19% -$296K 0.12% 58
2021
Q3
$1.8M Buy
392
+49
+14% +$332K 0.27% 46
2021
Q2
$2.36M Buy
343
+11
+3% +$75.9K 0.33% 44
2021
Q1
$2.43M Buy
332
+51
+18% +$428K 0.37% 45
2020
Q4
$2.27M Buy
281
+43
+18% +$387K 0.36% 45
2020
Q3
$2.43M Buy
238
+28
+13% +$230K 0.52% 38
2020
Q2
$1.41M Buy
210
+111
+112% +$764K 0.34% 43
2020
Q1
$449K Sell
99
-14
-12% -$70K 0.15% 50
2019
Q4
$683K Buy
+113
New +$722K 0.15% 56

Other funds holding RDHL

Gagnon Securities's RDHL Position: Q1 2026 in Review

Gagnon Securities increased its Redhill Biopharma (RDHL) stake by 2.7% in Q1 2026, buying an estimated $2.43K and bringing the position to 88,405 shares worth $65.9K. The position accounts for 0.02% of the portfolio, ranked #85.

Gagnon Securities first reported a position in RDHL in Q4 2019 and has held it in 20 quarters since. The position peaked at $2.43M in Q3 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.

  • Gagnon Securities held 88,405 shares of Redhill Biopharma worth $65.9K as of Q1 2026.
  • Gagnon Securities bought 2,303 Redhill Biopharma shares in Q1 2026, an estimated $2.43K.
  • Redhill Biopharma made up 0.02% of Gagnon Securities's portfolio in Q1 2026, its #85 holding.
  • Gagnon Securities first reported a position in Redhill Biopharma in Q4 2019 and has held it in 20 quarters since.
  • Gagnon Securities's Redhill Biopharma position peaked at $2.43M in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.

Based on Gagnon Securities's 13F filing for Q1 2026, filed 22 Apr 2026.